| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |